RecruitingNot ApplicableNCT05714033

A Randomized Trial Comparing a Ventilatory Strategy To Prevent Atelectasis Versus a Lateral Decubitus Strategy During Robotic Bronchoscopy (VESPA vs. LADS Trial)


Sponsor

M.D. Anderson Cancer Center

Enrollment

80 participants

Start Date

Feb 10, 2023

Study Type

INTERVENTIONAL

Conditions

Summary

To learn if LADS is better than VESPA at preventing atelectasis during a robotic bronchoscopy.


Eligibility

Min Age: 18 Years

Inclusion Criteria13

  • Adult patients (≥ 18 years old) undergoing diagnostic robotic bronchoscopy for a lung nodule suspicious for malignancy bronchoscopy under general anesthesia.
  • Lung nodules should be up to 3 cm in diameter and located in right or left bronchial segments B2, B6, B9, and B10. Greater than 50% of the volume of the lesion needs to be below a horizontal line traced at the most anterior edge of the corresponding vertebral body.
  • Chest CT performed \< 45 days prior to bronchoscopy.
  • Voluntary informed consent to participate in the study.
  • Known pregnancy
  • Vulnerable population
  • Ascites
  • Known diaphragmatic paralysis
  • Smokers or ex-smokers with known or suspected severe air-trapping defined as residual volume \> 150% of predicted
  • History of primary or secondary spontaneous pneumothorax
  • Lung bullae \> 5 cm
  • Patients with mediastinal or hilar adenopathy with high suspicion for malignancy in whom lymph node sampling is indicated and should occur prior to robotic bronchoscopy of the peripheral lesion.
  • Patient with active COVID pneumonia.

Exclusion Criteria1

  • Patients with prior lung consolidation, interstitial changes or lung masses (\> 3 cm in diameter) as seen on most recent CT

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

PROCEDUREVentilatory Strategy To Prevent Atelectasis

Given

PROCEDURELateral Decubitus Strategy (LADS)

Given


Locations(1)

M D Anderson Cancer Center

Houston, Texas, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT05714033


Related Trials